Vanguard Asset Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.29M Buy
73,096
+4,228
+6% +$177K ﹤0.01% 1132
2026
Q1
$2.22M Buy
+68,868
New +$2.55M ﹤0.01% 1407

Other funds holding VCYT

Vanguard Asset Management's VCYT Position: Q2 2026 in Review

Vanguard Asset Management increased its Veracyte (VCYT) stake by 6.1% in Q2 2026, buying an estimated $177K and bringing the position to 73,096 shares worth $4.29M. The position accounts for ﹤0.01% of the portfolio, ranked #1132.

Vanguard Asset Management first reported a position in VCYT in Q1 2026 and has held it in 2 quarters since. 364 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Vanguard Asset Management held 73,096 shares of Veracyte worth $4.29M as of Q2 2026.
  • Vanguard Asset Management bought 4,228 Veracyte shares in Q2 2026, an estimated $177K.
  • Veracyte made up ﹤0.01% of Vanguard Asset Management's portfolio in Q2 2026, its #1132 holding.
  • Vanguard Asset Management first reported a position in Veracyte in Q1 2026 and has held it in 2 quarters since.
  • 364 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Vanguard Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.